EU-SAFETY_HEALTH_WORK-PREAMBLE
EU-SAFETY_HEALTH_WORK-PREAMBLE
Safety and Health of Workers at Work Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)
This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.
Last updated 24 April 2024. Database contains 4691 unique substances/entries.
Filter the list
|
The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).
|
309-749-0
|
100801-66-9
|
Carc. 1B; Muta. 1B |
|
|
The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).
|
309-748-5
|
100801-65-8
|
Carc. 1B; Muta. 1B |
|
|
The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).
|
309-745-9
|
100801-63-6
|
Carc. 1B; Muta. 1B |
|
|
233-113-0
|
10035-10-6
|
Press. Gas; Skin Corr. 1A; STOT SE 3 |
||
|
233-113-0
|
10035-10-6
|
Skin Corr. 1B; STOT SE 3 |
||
|
233-109-9
|
10034-85-2
|
Skin Corr. 1B |
||
|
233-109-9
|
10034-85-2
|
Press. Gas; Skin Corr. 1A |
||
|
204-563-5
|
122-66-7
|
Carc. 1B; Acute Tox. 4 |
||
|
-
|
14913-74-7
|
Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
||
|
STABO-FIX
|
405-030-1
|
148434-03-1
|
Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
|
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
F Fungi |
||
|
-
|
-
|
F Fungi |
||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
Acute Tox. 4; Eye Dam. 1 |
|
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
Skin Sens. 1 |
|
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
Resp. Sens. 1; Skin Sens. 1 |
|
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
Eye Dam. 1 |
|
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
Eye Irrit. 2 |
|
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
Eye Dam. 1; Skin Sens. 1 |
|
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
||
|
-
|
-
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
||
|
209-731-1
|
591-78-6
|
Flam. Liq. 3; Repr. 2; STOT RE 1; STOT SE 3 |
||
|
203-852-3
|
111-27-3
|
Acute Tox. 4 |
||
|
211-653-8
|
680-31-9
|
Carc. 1B; Muta. 1B |
||
|
204-679-6
|
124-09-4
|
Acute Tox. 4; STOT SE 3; Skin Corr. 1B |
||
|
212-485-8
|
822-06-0
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
||
|
235-921-9
|
13048-33-4
|
Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
Acute Tox. 3; Skin Sens. 1 |
|
|
247-094-1
|
25550-51-0
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|
|
243-072-0
|
19438-60-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
Acute Tox. 4; Skin Sens. 1 |
|
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
|
-
|
-
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
||
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
||